Among 30 elderly patients who received ivermectin for the treatment of scabies, we observed a case of possible ivermectin-induced liver dysfunction in an 85 year-old patient. He developed liver dysfunction after the second dose of the drug. While elevated serum ALT and AST subsided to normal levels 2 months after discontinuation of the drug, increased serum ALP and γ-GPT persisted. Ivermectin was effective in all patients for the eradication of scabies.
